Brighton Cheryl A, Rievaj Juraj, Kuhre Rune E, Glass Leslie L, Schoonjans Kristina, Holst Jens J, Gribble Fiona M, Reimann Frank
University of Cambridge (C.A.B., J.R., L.L.G., F.M.G., F.R.), Metabolic Research Laboratories and Medical Research Council Metabolic Diseases Unit, Wellcome Trust-Medical Research Council Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; Novo Nordisk Foundation Center for Basic Metabolic Research and Department of Biomedical Sciences (R.E.K., J.J.H.), the Panum Institute, University of Copenhagen, Copenhagen, Denmark; and Institute of Bioengineering (K.S.), School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.
Endocrinology. 2015 Nov;156(11):3961-70. doi: 10.1210/en.2015-1321. Epub 2015 Aug 17.
Bile acids are well-recognized stimuli of glucagon-like peptide-1 (GLP-1) secretion. This action has been attributed to activation of the G protein-coupled bile acid receptor GPBAR1 (TGR5), although other potential bile acid sensors include the nuclear farnesoid receptor and the apical sodium-coupled bile acid transporter ASBT. The aim of this study was to identify pathways important for GLP-1 release and to determine whether bile acids target their receptors on GLP-1-secreting L-cells from the apical or basolateral compartment. Using transgenic mice expressing fluorescent sensors specifically in L-cells, we observed that taurodeoxycholate (TDCA) and taurolithocholate (TLCA) increased intracellular cAMP and Ca(2+). In primary intestinal cultures, TDCA was a more potent GLP-1 secretagogue than taurocholate (TCA) and TLCA, correlating with a stronger Ca(2+) response to TDCA. Using small-volume Ussing chambers optimized for measuring GLP-1 secretion, we found that both a GPBAR1 agonist and TDCA stimulated GLP-1 release better when applied from the basolateral than from the luminal direction and that luminal TDCA was ineffective when intestinal tissue was pretreated with an ASBT inhibitor. ASBT inhibition had no significant effect in nonpolarized primary cultures. Studies in the perfused rat gut confirmed that vascularly administered TDCA was more effective than luminal TDCA. Intestinal primary cultures and Ussing chamber-mounted tissues from GPBAR1-knockout mice did not secrete GLP-1 in response to either TLCA or TDCA. We conclude that the action of bile acids on GLP-1 secretion is predominantly mediated by GPBAR1 located on the basolateral L-cell membrane, suggesting that stimulation of gut hormone secretion may include postabsorptive mechanisms.
胆汁酸是公认的胰高血糖素样肽-1(GLP-1)分泌刺激物。这种作用归因于G蛋白偶联胆汁酸受体GPBAR1(TGR5)的激活,尽管其他潜在的胆汁酸传感器包括核法尼醇X受体和顶端钠依赖性胆汁酸转运体ASBT。本研究的目的是确定对GLP-1释放重要的途径,并确定胆汁酸是从顶端还是基底外侧区室作用于分泌GLP-1的L细胞上的受体。使用在L细胞中特异性表达荧光传感器的转基因小鼠,我们观察到牛磺脱氧胆酸(TDCA)和牛磺石胆酸(TLCA)增加了细胞内cAMP和Ca²⁺。在原代肠道培养物中,TDCA作为GLP-1分泌促进剂比牛磺胆酸(TCA)和TLCA更有效,这与对TDCA更强的Ca²⁺反应相关。使用优化用于测量GLP-1分泌的小容积尤斯灌流室,我们发现当从基底外侧而不是从管腔方向施加时,GPBAR1激动剂和TDCA都能更好地刺激GLP-1释放,并且当用ASBT抑制剂预处理肠道组织时,管腔TDCA无效。ASBT抑制在非极化原代培养物中没有显著影响。在灌注大鼠肠道中的研究证实,血管内给予TDCA比管腔TDCA更有效。来自GPBAR1基因敲除小鼠的肠道原代培养物和安装在尤斯灌流室上的组织对TLCA或TDCA均无反应分泌GLP-1。我们得出结论,胆汁酸对GLP-1分泌的作用主要由位于基底外侧L细胞膜上的GPBAR1介导,这表明肠道激素分泌的刺激可能包括吸收后机制。